Precigen, Inc. (FRA:I5X)
Germany · Delayed Price · Currency is EUR 4.178
+0.328 (8.52%)
At close: Jan 23, 2026
Precigen Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 6.24 | 3.89 | 6.22 | 26.66 | 13.77 | 31.27 |
Other Revenue | 0.07 | 0.03 | 0.01 | 0.25 | 0.5 | 0.72 |
| 6.31 | 3.93 | 6.23 | 26.91 | 14.27 | 31.99 | |
Revenue Growth (YoY) | 59.20% | -36.95% | -76.87% | 88.61% | -55.40% | -64.74% |
Cost of Revenue | 50.5 | 57.34 | 54.73 | 53.51 | 53.68 | 44.8 |
Gross Profit | -44.19 | -53.41 | -48.51 | -26.6 | -39.41 | -12.81 |
Selling, General & Admin | 63.48 | 41.29 | 40.42 | 48.01 | 51.99 | 72.69 |
Operating Expenses | 63.48 | 41.29 | 40.42 | 48.01 | 51.99 | 72.69 |
Operating Income | -107.67 | -94.71 | -88.92 | -74.61 | -91.41 | -85.5 |
Interest Expense | -0.9 | -0.01 | -0.47 | -6.77 | -18.76 | -18.21 |
Interest & Investment Income | 2.36 | 1.42 | 3.24 | 0.13 | 0.17 | 1.01 |
Earnings From Equity Investments | - | - | - | 0.86 | -0 | -0.6 |
Currency Exchange Gain (Loss) | - | -2.92 | - | - | - | - |
Other Non Operating Income (Expenses) | -139.55 | 0 | 0.63 | 1.54 | -0.43 | -0.4 |
EBT Excluding Unusual Items | -245.76 | -96.2 | -85.53 | -78.85 | -110.42 | -103.71 |
Impairment of Goodwill | -9.69 | -7.41 | -10.39 | -0.48 | - | - |
Gain (Loss) on Sale of Assets | 8.5 | 8.5 | - | - | - | - |
Asset Writedown | - | -32.92 | -0.45 | -0.64 | -0.54 | -0.81 |
Pretax Income | -246.95 | -128.03 | -96.36 | -79.97 | -110.97 | -104.52 |
Income Tax Expense | -0.08 | -1.79 | -0.46 | -0.19 | -0.16 | -0.08 |
Earnings From Continuing Operations | -246.87 | -126.24 | -95.9 | -79.78 | -110.81 | -104.44 |
Earnings From Discontinued Operations | - | - | - | 108.09 | 18.64 | -66.08 |
Net Income to Company | -246.87 | -126.24 | -95.9 | 28.32 | -92.17 | -170.52 |
Net Income | -246.87 | -126.24 | -95.9 | 28.32 | -92.17 | -170.52 |
Net Income to Common | -425.87 | -126.24 | -95.9 | 28.32 | -92.17 | -170.52 |
Shares Outstanding (Basic) | 298 | 268 | 245 | 200 | 198 | 167 |
Shares Outstanding (Diluted) | 298 | 268 | 245 | 200 | 198 | 167 |
Shares Change (YoY) | 15.98% | 9.48% | 22.05% | 1.31% | 18.37% | 8.39% |
EPS (Basic) | -1.43 | -0.47 | -0.39 | 0.14 | -0.47 | -1.02 |
EPS (Diluted) | -1.43 | -0.47 | -0.39 | 0.14 | -0.47 | -1.02 |
Free Cash Flow | -75.62 | -76.76 | -68.47 | -69.97 | -63.02 | -84.55 |
Free Cash Flow Per Share | -0.25 | -0.29 | -0.28 | -0.35 | -0.32 | -0.51 |
Gross Margin | - | - | - | -98.85% | -276.24% | -40.04% |
Operating Margin | -1706.63% | -2412.87% | -1428.48% | -277.25% | -640.67% | -267.27% |
Profit Margin | -6750.14% | -3216.18% | -1540.63% | 105.23% | -646.01% | -533.01% |
Free Cash Flow Margin | -1198.59% | -1955.59% | -1099.86% | -260.02% | -441.70% | -264.28% |
EBITDA | -104.95 | -90.18 | -82.26 | -63.84 | -77.64 | -67.99 |
EBITDA Margin | - | - | - | -237.25% | - | -212.52% |
D&A For EBITDA | 2.72 | 4.53 | 6.67 | 10.77 | 13.76 | 17.52 |
EBIT | -107.67 | -94.71 | -88.92 | -74.61 | -91.41 | -85.5 |
EBIT Margin | - | - | - | -277.25% | - | -267.27% |
Revenue as Reported | 6.31 | 3.93 | 6.23 | 26.91 | 14.27 | 31.99 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.